Exploring the Effects of Obesity and Bariatric Surgery on the Brain Using Magnetic Resonance Imaging
Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Nov 24, 2024
Trial Information
Current as of August 20, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how obesity and bariatric surgery (a type of weight-loss surgery) affect the brain, using a technique called Magnetic Resonance Imaging (MRI). The researchers want to understand how these factors might change brain structure and function, which could help improve treatments for obesity. They will look at brain scans from 200 obese patients who are planning to have bariatric surgery, comparing their scans before and six months after the surgery. They will also gather information on eating behaviors and hormones that influence hunger. To better understand the results, the study will include 60 healthy individuals of normal weight as a control group.
To participate in the trial, you must be at least 20 years old and have a body mass index (BMI) of 37.5 or higher, or a BMI of 27 or higher with related health issues like diabetes or high blood pressure. If you’re healthy and have a normal weight (BMI between 18.5 and 24), you can also join as a control participant. Participants will undergo MRI scans, answer questions about their eating habits, and provide blood samples. This study aims to shed light on how bariatric surgery might change brain activity related to eating and hunger, potentially leading to better obesity treatments in the future.
Gender
ALL
Eligibility criteria
- • A. Bariatric Surgery Participants
- Inclusion Criteria (Eligibility for Study Participation):
- • Aged 20 years or older.
- • Body mass index (BMI) ≥ 37.5, or BMI ≥ 27 with obesity-related comorbidities such as type 2 diabetes, hypertension, or obstructive sleep apnea.
- • Scheduled to undergo bariatric surgery for obesity treatment.
- Exclusion Criteria:
- • Presence of neurological or psychiatric disorders.
- • Use of neurological or psychiatric medications.
- • Diagnosis of cancer or major gastrointestinal diseases.
- • History of major abdominal surgery.
- • Presence of metallic implants in the body.
- • Claustrophobia.
- • Currently pregnant.
- • B. Healthy Normal-Weight Participants
- Inclusion Criteria (Eligibility for Study Participation):
- • Aged 20 to 65 years.
- • BMI between 18.5 and 24.
- Exclusion Criteria:
- • Presence of neurological or psychiatric disorders.
- • Use of neurological or psychiatric medications.
- • Diagnosis of cancer or major gastrointestinal diseases.
- • History of major abdominal surgery.
- • Presence of metallic implants in the body.
- • Claustrophobia.
- • Currently pregnant.
About National Taiwan University Hospital
National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Po-Jen Yang, MD, PhD
Principal Investigator
National Taiwan University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported